{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T15:14:13Z","timestamp":1759936453714},"reference-count":47,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.cjca.2013.09.017","type":"journal-article","created":{"date-parts":[[2013,12,25]],"date-time":"2013-12-25T07:45:27Z","timestamp":1387957527000},"page":"332-337","source":"Crossref","is-referenced-by-count":11,"title":["\u03b21-Selective Adrenoceptor Antagonists Increase Plasma Levels of Anti-p2\u03b2 Antibodies and Decrease Cardiac Involvement in Chronic Progressive Chagas Heart Disease"],"prefix":"10.1016","volume":"30","author":[{"given":"Miguel H.","family":"Vicco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nazarena","family":"Pujato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iv\u00e1n","family":"Bontempi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luz","family":"Rodeles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iv\u00e1n","family":"Marcipar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oscar A.","family":"Bottasso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjca.2013.09.017_bib1","first-page":"1","article-title":"Control of Chagas disease: second report of a WHO expert committee","volume":"905","year":"2002","journal-title":"World Health Organ Tech Rep Ser"},{"key":"10.1016\/j.cjca.2013.09.017_bib2","series-title":"Estimaci\u00f3n cuantitativa de la enfermedad de Chagas en las Am\u00e9ricas [Quantitative estimate of Chagas disease in the Americas]","year":"2006"},{"key":"10.1016\/j.cjca.2013.09.017_bib3","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S0300-8932(09)73071-4","article-title":"Update on Chagas heart disease on the first centenary of its discovery","volume":"62","author":"Marin-Neto","year":"2009","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.cjca.2013.09.017_bib4","first-page":"1096","article-title":"Determining the C-reactive protein level in patients with different clinical forms of Chagas disease","volume":"63","author":"Aparecida da Silva","year":"2010","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.cjca.2013.09.017_bib5","first-page":"147","article-title":"Nuclear changes in cells parasitized by Trypanosoma cruzi in chronic Chagas disease patients","volume":"20","author":"Almeida Hde","year":"1987","journal-title":"Rev Soc Bras Med Trop"},{"key":"10.1016\/j.cjca.2013.09.017_bib6","first-page":"43","article-title":"Denervation and heart disease in patients with chronic Chagas' disease","volume":"48","author":"Almeida Hde","year":"1987","journal-title":"Arq Bras Cardiol"},{"key":"10.1016\/j.cjca.2013.09.017_bib7","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S1471-4922(02)00006-5","article-title":"Etiology of Chagas disease myocarditis: autoimmunity, parasite persistence, or both?","volume":"19","author":"Giron\u00e8s","year":"2003","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.cjca.2013.09.017_bib8","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/0169-4758(96)10058-2","article-title":"Autoimmunity in Chagas disease cardiomyopathy: fulfilling the criteria at last?","volume":"12","author":"Kalil","year":"1996","journal-title":"Parasitol Today"},{"key":"10.1016\/j.cjca.2013.09.017_bib9","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0020-7519(01)00163-1","article-title":"Autoimmunity in Chagas heart disease","volume":"31","author":"Leon","year":"2001","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.cjca.2013.09.017_bib10","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1159\/000237653","article-title":"Immunological control of Trypanosoma cruzi infection and pathogenesis of Chagas disease","volume":"114","author":"Brener","year":"1997","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.cjca.2013.09.017_bib11","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/clc.4960101113","article-title":"The role of active myocarditis in the development of heart failure in chronic Chagas disease: a study based on endomyocardial biopsies","volume":"10","author":"Higuchi","year":"1987","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.cjca.2013.09.017_bib12","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1006\/jaut.2001.0574","article-title":"Experimental chronic Chagas disease myocarditis is an autoimmune disease preventable by induction of immunological tolerance to myocardial antigens","volume":"18","author":"Pontes-de-Carvalho","year":"2002","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.cjca.2013.09.017_bib13","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1590\/S0001-37652001000400008","article-title":"The pathogenesis of Chagas disease: when autoimmune and parasite-specific immune responses meet","volume":"73","author":"Soares","year":"2001","journal-title":"An Acad Bras Cienc"},{"key":"10.1016\/j.cjca.2013.09.017_bib14","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1038\/nature09221","article-title":"Chagas disease: a new worldwide challenge","volume":"465","author":"Coura","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.cjca.2013.09.017_bib15","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.actatropica.2010.03.008","article-title":"Chagas disease: 100 years after its discovery. A systemic review","volume":"115","author":"Coura","year":"2010","journal-title":"Acta Trop"},{"key":"10.1016\/j.cjca.2013.09.017_bib16","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/B978-0-12-385895-5.00006-2","article-title":"Autoimmunity","volume":"76","author":"Cunha-Neto","year":"2011","journal-title":"Adv Parasitol"},{"key":"10.1016\/j.cjca.2013.09.017_bib17","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jneuroim.2004.04.012","article-title":"Modulatory effects on myocardial physiology induced by an anti-monoclonal antibody involve recognition of major antigenic epitopes from \u03b2-adrenergic and M-muscarinic cholinergic receptors without requiring receptor cross-linking","volume":"153","author":"Cremaschi","year":"2004","journal-title":"J\u00a0Neuroimmunol"},{"key":"10.1016\/j.cjca.2013.09.017_bib18","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0166-6851(03)00003-3","article-title":"Trypanosoma cruzi antigen that interacts with the \u03b21-adrenergic receptor and modifies myocardial contractile activity","volume":"127","author":"Joensen","year":"2003","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.cjca.2013.09.017_bib19","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1084\/jem.182.1.59","article-title":"Molecular mimicry between the immunodominant ribosomal protein P0 of Trypanosoma cruzi and a functional epitope on the human beta 1-adrenergic receptor","volume":"182","author":"Ferrari","year":"1995","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.cjca.2013.09.017_bib20","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1365-2249.2007.03381.x","article-title":"Anti-beta1-adrenergic receptor autoantibodies in patients with chronic Chagas heart disease","volume":"148","author":"Labovsky","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.cjca.2013.09.017_bib21","first-page":"1","article-title":"Human recombinant antibodies against Trypanosoma cruzi ribosomal P2 \u03b2 protein","author":"Grippo","year":"2011","journal-title":"Parasitology"},{"key":"10.1016\/j.cjca.2013.09.017_bib22","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.ijpara.2010.12.010","article-title":"Antibodies against the Trypanosoma cruzi ribosomal P proteins induce apoptosis in HL-1 cardiac cells","volume":"41","author":"Levy","year":"2011","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.cjca.2013.09.017_bib23","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1006\/jmcc.1996.0307","article-title":"Peptides derived from cardiovascular G-protein-coupled receptors induce morphological cardiomyopathic changes in immunized rabbits","volume":"29","author":"Matsui","year":"1997","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.cjca.2013.09.017_bib24","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1096\/fj.01-0132com","article-title":"Antibodies against the carboxyl-terminal end of the Trypanosoma cruzi ribosomal P proteins are pathogenic","volume":"15","author":"L\u00f3pez Bergami","year":"2001","journal-title":"FASEB J"},{"key":"10.1016\/j.cjca.2013.09.017_bib25","doi-asserted-by":"crossref","first-page":"4203","DOI":"10.4049\/jimmunol.157.9.4203","article-title":"Structural and functional analysis of the B cell epitopes recognized by anti-receptor autoantibodies in patients with Chagas disease","volume":"157","author":"Elies","year":"1996","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.cjca.2013.09.017_bib26","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ijcard.2010.05.033","article-title":"Effects of \u03b2-blockers on outcome of patients with Chagas cardiomyopathy with chronic heart failure","volume":"151","author":"Bestetti","year":"2011","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cjca.2013.09.017_bib27","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1161\/CIRCHEARTFAILURE.109.882035","article-title":"\u03b2-Blocker therapy and mortality of patients with Chagas cardiomyopathy: a subanalysis of the REMADHE prospective trial","volume":"3","author":"Issa","year":"2010","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cjca.2013.09.017_bib28","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1745-6215-7-21","article-title":"CHARITY: Chagas cardiomyopathy bisoprolol intervention study: a randomized double-blind placebo force-titration controlled study with bisoprolol in patients with chronic heart failure secondary to Chagas cardiomyopathy [NCT00323973]","volume":"7","author":"Quiros","year":"2006","journal-title":"Trials"},{"key":"10.1016\/j.cjca.2013.09.017_bib29","unstructured":"Marcipar S, Lagier C. Advances in serological diagnosis of Chagas' disease by using recombinant proteins. In: Rodriguez-Morales A, ed. Current\u00a0Topics in Tropical Medicine. Available at: http:\/\/www.intechopen.com\/books\/current-topics-in-tropicalmedicine\/advances-in-serological-diagnosis-of-chagas-disease-by-using-recombinant-proteins. Accessed March 7, 2013."},{"key":"10.1016\/j.cjca.2013.09.017_bib30","first-page":"160","article-title":"Clasificaci\u00f3n cl\u00ednica de la miocardiopat\u00eda chag\u00e1sica cr\u00f3nica e historia natural [Clinical classification and natural evolution of chronic Chagas cardiomyopathy]","volume":"63","author":"Storino","year":"1985","journal-title":"Bol Acad Nac de Medicina (Bs As)"},{"key":"10.1016\/j.cjca.2013.09.017_bib31","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/eurheartj\/ehs104","volume":"33","author":"McMurray","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2013.09.017_bib32","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1056\/NEJMoa053241","article-title":"Development and validation of a risk score for predicting death in Chagas' heart disease","volume":"355","author":"Rassi","year":"2006","journal-title":"N\u00a0Engl J Med"},{"issue":"suppl 2","key":"10.1016\/j.cjca.2013.09.017_bib33","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.recesp.2012.07.006","article-title":"Risk stratification in Chagas disease","volume":"65","author":"Barbosa","year":"2012","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"10.1016\/j.cjca.2013.09.017_bib34","doi-asserted-by":"crossref","first-page":"5498","DOI":"10.1128\/JCM.43.11.5498-5503.2005","article-title":"Use of full-length recombinant calflagin and its c fragment for improvement of diagnosis of Trypanosoma cruzi infection","volume":"43","author":"Marcipar","year":"2005","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.cjca.2013.09.017_bib35","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1128\/CVI.00005-09","article-title":"Comparison of recombinant Trypanosoma cruzi peptide mixtures versus multiepitope chimeric proteins as sensitizing antigens for immunodiagnosis","volume":"16","author":"Camussone","year":"2009","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.cjca.2013.09.017_bib36","unstructured":"Tijssen, P. Processing of data and reporting of results of enzyme immunoassays. In: Practice and Theory of Enzyme Immunoassays. Laboratory Techniques in Biochemistry and Molecular Biology, Vol. 15. Amsterdam, London, New York, Tokyo: Elsevier, 1985:385-421."},{"key":"10.1016\/j.cjca.2013.09.017_bib37","doi-asserted-by":"crossref","first-page":"435","DOI":"10.20506\/rst.12.2.691","article-title":"Standardisation and validation of enzyme-linked immunosorbent assay techniques for the detection of antibody in infectious disease diagnosis","volume":"12","author":"Wright","year":"1993","journal-title":"Rev Sci Tech"},{"key":"10.1016\/j.cjca.2013.09.017_bib38","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1128\/JCM.01043-06","article-title":"Design, construction, and evaluation of a specific chimeric antigen to diagnose chagasic infection","volume":"44","author":"Aguirre","year":"2006","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.cjca.2013.09.017_bib39","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1161\/CIRCULATIONAHA.106.627323","article-title":"Echocardiography in Chagas heart disease","volume":"115","author":"Acquatella","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2013.09.017_bib40","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1016\/j.micinf.2006.06.006","article-title":"Levels of anti-M2 and anti-beta1 autoantibodies do not correlate with the degree of heart dysfunction in Chagas heart disease","volume":"8","author":"Talvani","year":"2006","journal-title":"Microbes Infect"},{"key":"10.1016\/j.cjca.2013.09.017_bib41","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1590\/S0074-02762002000300002","article-title":"Integrate study of a Bolivian population infected by Trypanosoma cruzi, the agent of Chagas disease","volume":"97","author":"Breni\u00e8re","year":"2002","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.cjca.2013.09.017_bib42","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.recesp.2013.05.028","article-title":"Assessment of cross-reactive host-pathogen antibodies in patients with different stages of chronic Chagas disease","volume":"66","author":"Vicco","year":"2013","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.cjca.2013.09.017_bib43","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.ahj.2013.01.001","article-title":"Matrix metalloproteinases 2 and 9 as diagnostic markers in the progression to Chagas cardiomyopathy","volume":"165","author":"Bautista-L\u00f3pez","year":"2013","journal-title":"Am Heart J"},{"key":"10.1016\/j.cjca.2013.09.017_bib44","doi-asserted-by":"crossref","first-page":"575","DOI":"10.4269\/ajtmh.2011.10-0261","article-title":"Humoral immune response against P2\u03b2 from Trypanosoma cruzi in persons with chronic Chagas disease: its relationship with treatment against parasites and myocardial damage","volume":"84","author":"Fabbro","year":"2011","journal-title":"Am J Trop Med Hyg"},{"issue":"suppl 1","key":"10.1016\/j.cjca.2013.09.017_bib45","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1590\/S0074-02762009000900042","article-title":"The BENEFIT trial: testing the hypothesis that trypanocidal therapy is beneficial for patients with chronic Chagas heart disease","volume":"104","author":"Marin-Neto","year":"2009","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.cjca.2013.09.017_bib46","first-page":"273","article-title":"Beneficial effects of enalapril on the diastolic ventricular function in Chagas myocardiopathy","volume":"60","author":"Szajnbok","year":"1993","journal-title":"Arq Bras Cardiol"},{"key":"10.1016\/j.cjca.2013.09.017_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.ahj.2006.12.017","article-title":"A\u00a0randomized trial of carvedilol after renin-angiotensin system inhibition in chronic Chagas cardiomyopathy","volume":"153","author":"Botoni","year":"2007","journal-title":"Am Heart J"}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X13014657?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X13014657?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,9]],"date-time":"2023-07-09T08:40:24Z","timestamp":1688892024000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X13014657"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S0828282X13014657"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2013.09.017","relation":{},"ISSN":["0828-282X"],"issn-type":[{"value":"0828-282X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]}}}